InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Thursday, 10/08/2020 2:26:18 AM

Thursday, October 08, 2020 2:26:18 AM

Post# of 403170
NEJM 10/8 MERS article . Did you say MERS? Like the corona virus CEO referred to four months ago already>. As a B target? And one of the reason RBL and IP would submit a grant together?

Yikes - so much for an update...

Meanwhile , in the real world, NEJM has an article on new therapy.

Where, oh where is B?

recall folks: we are advised it is GOOD NEWS there are delays in data. Good because it means they want to do more and it must be going well.

Is this the most obvious nonsense? or what? Get a move on IP you are losing out.

Trial trial trial is all that counts and every single day with no prepublication is another dagger in the heart of IP as other therapies move forward and B does not. Now we have a MERS trial in the NEJM. When does the B MERS testing start? Gee, I don''t know. And neither does anybody else. Could it be that the CEO thinks we are all morons, and do not care, or we are demented fools who have forgotten a critical PR 4 months ago??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News